Allograft tolerance induced by cyclophosphamide without prior inoculation of donor cells-immune suppression and redirection

Transplant Immunology

Volumn 8, Issue 1, 2000, Pages 65-73

  Gao, Zu Hua ^a   Lazarovits, Andrew I ^a   Wang, Jiaojing ^a   Xing, Jingjing ^a   Garcia, Bertha ^a   Kellersmann, Richard ^b   Kelvin, David ^c   Zhong, Robert ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Allograft; Cyclophosphamide; Donor cells; Tolerance

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN M; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOLOGY; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INOCULATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFORMATION; LYMPHOCYTOPENIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; TH2 CELL; XENOGRAFT;

ANIMALS; CYCLOPHOSPHAMIDE; CYTOKINES; HEART TRANSPLANTATION; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA; MYOCARDIUM; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034069784     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(00)00013-7     Document Type: Article

References (45)

1. Berenbaum MC'. Prolongation of hoinogiaft survival in mice with single dose ol cyclophosphamide. Nature 1%3;200:84.
2. Fox M. Suppression of tissue imniunity hy cyclophosphamide. Transplantation 1964;64:475-486.
3. Fearson FM. Fox M. Auderson CK et al. Cyclophosphainide in renal honiolransplautation. Br .1 Urol 1966;38:673-676
4. Reams GB. l;se of cyclophosphamide in an attempt to modify the canine renal homograft response. Nature 1963:197:713-714.
5. Starazl TH. Putnam C.V. Halgrimson (Xi et al. Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Ohstet 1971:133:981-991.
6. Slarazl TE H. lalgrimson CG. Penn I et al. Cyclophosphamide and human organ transplantation. Lancet 1971:2:70 74.
7. Morschhcuser T, Steinhoff J, Indzhiia I, et al. Successful down-regulation of natural and xenoreactive antibodies in pigto-baboon xenotransplaiitation by high-dose cyclophosphamide. Iransplant Proc 1997;29:970-972.
8. Tilney ML. Whiteley WD. Diamond JR. Kupiec-Weglinski JW. Adams Oil. Chronic rejection an undefined conundrum. Transplantation 1991;52:389-398.
9. Mayumi II. Wood RA. The necessity of both allogeneic antigens and stem cells foi cvclophosphamide induced skin allogratt tolerance in mice. Immunobiology lcwy;178:287-304.
10. Mayumi H. Good RA. Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (mnltimajor H-2 phis multiminor histocompaiibility) antigen barrieis by tolerance-inducing method using cyelophosphamide. J F.xp Med 1989;169:213-238.
11. hto M. Mayumi II. Toniita et al. Sequential mechanism of cyclophosphaniide-induced skin allografl tolerance including the inlrathyniic donal deletion followed by late breakdown of the clonal deletion. J Immunol 1990;145:1303-1310.
12. Mayumi II, L'mesue M, Nomoto K. Cyclophosphamide-induced immunological toleiaiice: an overview. Immunobiology 1996;195:129-139.
13. Olfel HD. Cross BM. McWilliam AA. (Juide to the care and use ol experimental animals. 2nd edition Ottawa: Canadian Council on Animal Care. 1997.
14. Cony R.I. Russell PS. New possibilities foi organ allografting in the mouse. Immunological aspects of transplantation surgery. New York: Wiley, 1973:279-283.
15. Zhang Z, Zhu LF, Quan D et al. Pattern of liver, kidney, heart, and intestine allograft rejection in different mouse strain combinations. Transplantation 1996;62:1267-1272.
16. Umesue M, Mayumi H, Nishimura Y et al. Donor-specific prolongation of rat skin graft survival induced by rat-donor cells and cyclophosphamide under coadministration of monoclonal antibodies against T cell receptor a and natural killer cells in mice. Transplantation 1996;61:116-124.
17. Pohanka E, Zlabinger GJ, Mayer G et al. Comparison of serum neopterin levels and spontaneous blastogenesis in monitoring of kidney graft recipients. Transplant Proc 1988;20:110-115.
18. Onodera K, Lehmann M, Akalin E, Volk HD, Sayegh MH, Kupiec-Weglinski JW. Induction of 'infectious' tolerance to MHC incompatible cardiac allografts in CD4 mAb-treated sensitized rat recipients. J Immunol 1996;157:1944-1950.
19. Strom TB, Roy-Chaudhury P, Manfro R et al. The Thl/Th2 paradigm and allograft response. Curr Opin Immunol 1996; 8:688-693.
20. Schwartz R, Dameshek W. Drug-induced immunological tolerance. Nature 1959;183:1682-1683.
21. Santos GW, Owens AH. A comparison of the effects of selected cytotoxic agents on allogenic skin graft survival in rat. Bull Johns Hopkins Hosp 1965;! 16:327-340.
22. Maeda T, Eto M, Nishimura Y. Nomoto K, Kong Y, Nomoto K. Direct evidence for clonal destruction of alloreactive T cells in the mice treated with cyclophosphamide after allo-priming. Immunology 1993;78:113-121.
23. Zhang Q, Hisanori M, Masayoshi U, Yukihiro T, Kikuo N, Hisataka Y. Fractionated dosing of cyclophosphamide for establishing long-lasting skin allograft survival, stable mixed chimerism and intrathymic clonal deletion in mice primed with allogeneic spleen cells. Transplantation 1997;63:1667-1673.
24. Dallman MJ, Wood KJ, Morris PJ. Specific cytotoxic T cells are found in the nonrejected kidneys of blood-transfused rats. J Exp Med 1987;165:566-571.
25. Armstrong HE, Bolton EM, McMillan I, Spencer SC, Bradley JA. Prolonged survival of actively enhanced rat renal allografts despite accelerated cellular infiltration and rapid induction of both class I and class II MHC antigens. J Exp Med 1987; 165:891-907.
26. Lazarovits AI, Poppema S, Zhang Z et al. Prevention and reversal of renal allograft rejection by antibody against CD45RB. Nature 1996;380:717-720.
27. Eechler R, Bluestone JA. Transplantation tolerance-putting the pieces together. Curr Opin Immunol 1997;9:631-633.
28. Larsen CP, Elwood ET, Alexander DZ et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996;381:434-438.
29. Yamamoto H, Kaneda K, Kamada N, Wake K. Morphometric analysis of infiltrating cells that adhere to the sinusoidal wall and migrate into the space of disse in the orthotopically trans-planted rat liver. Transplantation 1994;58:8-13.
30. Reed EF, Hong B, Ho E, Harris PE, Weinberger J, Suciu-Foca N. Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease. Transplantation 1996; 61:566-572.
31. Ramshaw JA, Bretscher PA, Parish CR. Regulation of the immune response, II. Represser cells in cyclophosphamideinduced tolerant mice. Eur J Immunol 1977;7:180-185.
32. Smith PC, Sladek NE. Sensitivity of murine B- and T-lymphocytes to oxazaphosphorine and non-oxazaphosphorine nitrogen mustards. Biochem Pharmacol 1985;34:3459-3463.
33. Lerman SP, Weidanz WP. The effect of cyclophosphamide on the ontogeny of the humoral immune response in chickens. J Immunol 1970:105:614-619.
34. Stockman GD, Heim LR, South MA, Trentin JJ. Differential effects of cyclophosphamide on the B and T cell compartments of adult mice. J Immunol 1973:110:277-282.
35. Drossier K, Klima F, Ambrosius H. The influence of cyclophosphamide and 6-mercaptopurine on the IgGl and IgG2 immune response in guinea pigs. Immunology 1981;44:61-66.
36. Finkelman FD, Katona IM, Mosmann TR, Coffman RL. IFN-y regulates the isotypes of Ig secreted during in vivo humoral responses. J Immunol 1988:140:1022-1027.
37. Snapper CM, Peschel C, Paul WE. IFN-y stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharide. J Immunol 1988;140:2121-2127.
38. Bona CA, Bonilla FA. Immunologie tolerance. In: Bona CA, Bonilla FA. editors. Textbook of immunology. Harwood Academic, 1996:108-118.
39. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RE. Two types of murine helper T cell clone: I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-2357.
40. Takeuchi T. Eowry RP, Koieczny B. Heart allografts in murine systems: the differential activation of Th2-like effectors in peripheral tolerance. Transplantation 1992;53:1281-1294.
41. Mottram PL, Han W-R, Purcell LJ, Mckenzie IFC, Hancock WW. Increased expression of IE-4 and IE-10 and decreased expression of IE-2 and interferon-r in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Transplantation 1995:59:559-565.
42. Ramirez F, Fowell DJ, Puklavec M, Simmonds S, Mason D. Glucocorticoids promote a Th2 cytokine response by CD4 T cells in vitro. J Immunol 1996:156 2406-2412.
43. Chen N. Gao Q, Field EH. Prevention of Thl response is critical for tolerance. Transplantation 1996;61:1076-1083.
44. Steiger JP, Nickerson W, Steurer W, Moscovitch-Eopatin M, Strom TB. IE-2 knockout recipient mice reject islet cell allografts. J Immunol 1995;155:489 498.
45. Knnieczny BT, Saleem SS, Eowry RP, Eakkis FG. Vigorous cardiac and skin allograft rejection in the absence of IFNγ. J Am Soc Nephrol 1996:7:1887-1895.